These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21799049)
1. Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867. Dayton A; Selvendiran K; Meduru S; Khan M; Kuppusamy ML; Naidu S; Kálai T; Hideg K; Kuppusamy P J Pharmacol Exp Ther; 2011 Nov; 339(2):350-7. PubMed ID: 21799049 [TBL] [Abstract][Full Text] [Related]
2. Is the combinational administration of doxorubicin and glutathione a reasonable proposal? Shen BY; Chen C; Xu YF; Shen JJ; Guo HM; Li HF; Li XN; Kang D; Shao YH; Zhu ZP; Yin XX; Xie L; Wang GJ; Liang Y Acta Pharmacol Sin; 2019 May; 40(5):699-709. PubMed ID: 30218071 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice. Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318 [TBL] [Abstract][Full Text] [Related]
4. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells. Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637 [TBL] [Abstract][Full Text] [Related]
5. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity. Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569 [TBL] [Abstract][Full Text] [Related]
6. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917 [TBL] [Abstract][Full Text] [Related]
7. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425 [TBL] [Abstract][Full Text] [Related]
8. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Chularojmontri L; Wattanapitayakul SK; Herunsalee A; Charuchongkolwongse S; Niumsakul S; Srichairat S Biol Pharm Bull; 2005 Jul; 28(7):1165-71. PubMed ID: 15997091 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
10. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Xu HB; Shen ZL; Fu J; Xu LZ Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783 [TBL] [Abstract][Full Text] [Related]
11. Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection. Alfaro Y; Delgado G; Cárabez A; Anguiano B; Aceves C Mol Cancer; 2013 May; 12():45. PubMed ID: 23705792 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment. Sacks B; Onal H; Martorana R; Sehgal A; Harvey A; Wastella C; Ahmad H; Ross E; Pjetergjoka A; Prasad S; Barsotti R; Young LH; Chen Q BMC Pharmacol Toxicol; 2021 Sep; 22(1):49. PubMed ID: 34530934 [TBL] [Abstract][Full Text] [Related]
13. Genistein protects against doxorubicin-induced cardiotoxicity through Nrf-2/HO-1 signaling in mice model. Bai Z; Wang Z Environ Toxicol; 2019 May; 34(5):645-651. PubMed ID: 30734460 [TBL] [Abstract][Full Text] [Related]
14. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related]
15. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction. Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms. Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974 [TBL] [Abstract][Full Text] [Related]
17. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069 [TBL] [Abstract][Full Text] [Related]
18. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis. Jin J; Sun H; Wei H; Liu G Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080 [TBL] [Abstract][Full Text] [Related]
19. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro. Chahine N; Nader M; Duca L; Martiny L; Chahine R Drug Chem Toxicol; 2016; 39(1):87-96. PubMed ID: 25885550 [TBL] [Abstract][Full Text] [Related]
20. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model. Shuhendler AJ; Prasad P; Zhang RX; Amini MA; Sun M; Liu PP; Bristow RG; Rauth AM; Wu XY Mol Pharm; 2014 Aug; 11(8):2659-74. PubMed ID: 24830351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]